Appears On
Episode Appearances
Radiolab · May 22, 2026
Worth
“Noticed cancer drug prices skyrocketing; led boycott of Zaltrap and op-ed criticizing $11,000/month pricing for minimal benefit”
Cancer Drug Pricing and Cost-Benefit AnalysisHealthcare Cost Transparency and Patient Decision-MakingHepatitis C Treatment Access and State Rationing
View Analysis